Association of hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ with UGT1A1 polymorphisms

被引:0
作者
Johnson, Toby
Xu, Chun-fang
Choueiri, Toni K.
Deen, Keith C.
Xue, Zhengyu
Bartlett-Pandite, Arundathy N.
Carpenter, Christopher
Motzer, Robert John
机构
[1] GlaxoSmithKline, Uxbridge, Middx, England
[2] GlaxoSmithKline, Harlow, Essex, England
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] GlaxoSmithKline, Collegeville, PA USA
[5] GlaxoSmithKline, Res Triangle Pk, NC USA
[6] GlaxoSmithKline Res & Dev Ltd, Collegeville, PA USA
[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4569
引用
收藏
页数:1
相关论文
共 50 条
[31]   Severe Neonatal Hyperbilirubinemia and UGT1A1 Promoter Polymorphism [J].
Travan, Laura ;
Lega, Sara ;
Crovella, Sergio ;
Montico, Marcella ;
Panontin, Elisa ;
Demarini, Sergio .
JOURNAL OF PEDIATRICS, 2014, 165 (01) :42-45
[32]   UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association? [J].
Laura Alencastro de Azevedo ;
Themis Reverbel da Silveira ;
Clarissa Gutierrez Carvalho ;
Simone Martins de Castro ;
Roberto Giugliani ;
Ursula Matte .
Pediatric Research, 2012, 72 :169-173
[33]   Polymorphisms of the UGT1A1 gene and cholelithiasis [J].
Chaouch, L. ;
Said, Y. ;
Mahjoubi, I. ;
Chaabene, A. B. ;
Douzi, K. ;
Ouerhani, S. ;
Abbes, S. .
TISSUE ANTIGENS, 2011, 77 (05) :428-428
[34]   816 Ugt1A1 Gene Variants in Neonatal Hyperbilirubinemia [J].
A Kumar ;
P K Tiwari ;
A Bhutada ;
R Agarwal ;
R Raman .
Pediatric Research, 2010, 68 :410-410
[35]   Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia [J].
Teh, L. K. ;
Hashim, H. ;
Zakaria, Z. A. ;
Salleh, M. Z. .
INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 136 (02) :249-259
[36]   UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia [J].
Carpenter, Shannon L. ;
Lieff, Susan ;
Howard, Thad A. ;
Eggleston, Barry ;
Ware, Russell E. .
AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (10) :800-803
[37]   Effects of Shengjiangxiexin decoction on irinotecan-induced toxicity in patients with UGT1A1*28 and UGT1A1*6 polymorphisms [J].
Deng Bo ;
Jia Liqun ;
Tan Huangying ;
Lou Yanni ;
Li Xue ;
Li Yuan ;
Yu Lili .
Journal of Traditional Chinese Medicine, 2017, 37 (01) :35-42
[38]   286 Polymorphisms in Ugt1A1 Gene Among North Indian Neonates Presenting with Unconjugated Hyperbilirubinemia [J].
R Rathi ;
S Aggarwal ;
P Kumar ;
N Khullar ;
R Prasad .
Pediatric Research, 2010, 68 :147-147
[39]   The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan [J].
Su, Y. -y. ;
Chiang, N. -j. ;
Chang, J. S. ;
Wang, Y. -w. ;
Shen, B. -n. ;
Li, Y. -j. ;
Hwang, D. -y. ;
Shan, Y. -s. ;
Chen, L. -t .
ESMO OPEN, 2023, 8 (01)
[40]   DISTINCT ASSOCIATIONS BETWEEN UGT1A1 GENE PROMOTER POLYMORPHISM AND HYPERBILIRUBINEMIA IN CML PATIENTS TREATED WITH NILOTINIB AND RADOTINIB [J].
Kim, S. ;
Choi, S. Y. ;
Lee, S. E. ;
Yoo, H. L. ;
Oh, Y. J. ;
Lee, M. Y. ;
Jang, E. J. ;
Choi, M. Y. ;
Jang, M. M. ;
Kim, D. W. .
HAEMATOLOGICA, 2015, 100 :684-685